Oncology & Hematology Coding Alert

Reader Questions:

Watch POS When Reporting Q3001

Question: Can our office receive compensation for supplying brachytherapy prostate seeds? Texas Subscriber Answer: Yes, you may. If your private practice bears the cost of purchasing radioactive sources, such as prostate seeds, used for an individual patient for brachytherapy treatments, you may report Q3001 (Radioelements for brachytherapy, any type, each) in the office or independent clinic setting. For example, if the physician planted 85 sources, you would report Q3001 with 85 units. Documentation should include dosage, unit price per dose, the name of the radioactive drug or element, and the total charge.
Expect an increase in payer requests for invoices. Your payer may only reimburse you for the invoice amount. Place of service is crucial: Medicare will reimburse Q3001 only in an office or free-standing radiological facility (POS 11) or independent clinic (POS 49). In an ambulatory surgical center (ASC), you would report the same "C" codes you-d apply for outpatient hospital reimbursement.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All